Development of assays and reagents for zika virus vaccines (task area 2)

Ended Awarded Last action

Contract number
HHSN27200019
Awardee
Awarding agency
Obligated
$4,494,466

Award facts

Contract value 95% obligated
  • $4,494,465.72 Current, with exercised options
  • $4,711,331.72 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00013 · The purpose of this modification is to DE-obligate remaining funds and administratively close the task order. -$170,528
Supplemental Agreement for work within scope P00012 $0
Supplemental Agreement for work within scope P00011 $55,426
Supplemental Agreement for work within scope P00010 $0
Supplemental Agreement for work within scope P00009 $516,191
Supplemental Agreement for work within scope P00008 $66,761
Supplemental Agreement for work within scope P00007 $522,393
Supplemental Agreement for work within scope 6 $93,431
Exercise an Option 5 $582,575
Supplemental Agreement for work within scope 4 $673,163
Exercise an Option 3 $737,459
Exercise an Option 2 $184,031
Other Administrative Action 1 $0
Original award $1,233,564
Show all 14

About this award

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $4,711,331.72 contract involves the development of assays and reagents for Zika virus vaccines under Task Area 2. It is a cost-plus-fixed-fee Delivery Order contract with a period of performance ending on February 28, 2022. The contract is not associated with a set-aside program. Battelle has previously held other major IDIQ contracts with HHS, EPA, and DARPA for a range of research, testing, and technical services in fields like biodefense, environmental remediation, and transportation security. The award includes a $100,000 sub-contract to Hennessy Research Associates for the supply of a specific monoclonal antibody.

Quick answers

Who was awarded contract HHSN27200019?

HHSN27200019 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2016.

How much is contract HHSN27200019 worth?

The government has obligated $4,494,466 on HHSN27200019. Its potential value, with all options, is $4,711,332.

Is contract HHSN27200019 an order under another contract?

Yes. HHSN27200019 is a delivery order under HHSN272201200003I, an indefinite delivery contract.

Was contract HHSN27200019 competed?

The extent of competition for HHSN27200019 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award